VAGELOS P ROY 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 21, 2022
Insider Transaction Report
Form 4
VAGELOS P ROY
Director
Transactions
- Discretionary Transaction
Common Stock
2022-12-20$729.71/sh−111$80,998→ 1,961 total(indirect: By 401(k)) - Discretionary Transaction
Common Stock
2022-12-20$728.86/sh−30$21,866→ 2,072 total(indirect: By 401(k))
Holdings
- 324,083
Common Stock
- 3,609(indirect: By Trust)
Common Stock
- 126,043(indirect: by CLAT)
Common Stock
- 23,461(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Represents volume-weighted average price of sales of 30 shares of Company stock on December 20, 2022 at prices ranging from $728.81 to $728.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price.
- [F2]Represents volume-weighted average price of sales of 111 shares of Company stock on December 20, 2022 at prices ranging from $729.44 to $729.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 20, 2022 at each separate price.
- [F3]By trusts for the benefit of nine grandchildren of the reporting person, each of which holds 401 shares of Company stock. The reporting person and/or the spouse of the reporting person is the trustee of each such trust.